HRC News and Press, Hill-Rom Holdings Inc From 03/11/21

Hillrom Announces 9 Percent Increase in Quarterly Dividend PR Newswire CHICAGO , March 11, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) announced today that its board of directors declared a 9 percent increase in the company's quarterly dividend rate, ...

Hillrom to Present at KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum Hillrom to Present at KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum PR Newswire CHICAGO , March 10, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) t...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha, Apple Po...

Irhythm (IRTC) talks with Novitas on reimbursement rates for ECG monitoring may not work out in IRTC's favor after news that Hill-Rom (HRC) is attempting to get out of its $375m purchase of Bardy, also a maker of an ECG monitoring device, according to Oppenheimer.The Hill-Rom-Bardy breakup su...

Hill-Rom (HRC) is trying to exit its planned $375m purchase of Bardy Diagnostics Inc. as it believes that a "material adverse effect" occurred due to the unexpected unexpected Novitas reimbursement rate reduction.BardyDx has advised Hill-Rom that it has filed a complaint against Hill-Rom...

Hillrom Provides Update on Planned Acquisition of Bardy Diagnostics, Inc. PR Newswire CHICAGO , March 1, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) today provided an update on its planned acquisition of Bardy Diagnostics, Inc. (BardyDx), which it previousl...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead Investors have a variety of events and developments to focus on next week. The impact of the pending FDA approval on Joh...

The following slide deck was published by Hill-Rom Holdings, Inc. in conjunction with their 2021 Q1 earnings call. For further details see: Hill-Rom Holdings, Inc. 2021 Q1 - Results - Earnings Call Presentation

Hill-Rom Holdings (HRC) earlier declined to say much about its recent planned purchase of Bardy Diagnostics after Novitas last month announced category 1 reimbursement rates that analysts said were well below current rates.Recall that Bardy competitor iRhythm (IRTC) declined 33% in one day af...

Hill-Rom Holdings, Inc. (HRC) Q1 2021 Earnings Conference Call February 5, 2021 08:30 ET Company Participants Mary Kay Ladone - Senior Vice President, Corporate Development, Strategy and Investor Relations John Groetelaars - President and Chief Executive Officer Barbara Bodem - Chief Financia...